About this trial

The purpose of this study is to gather safety and effectiveness of the Zenith t-Branch and customized physician-specified stent-graft with a combination of fenestrations and/or branches to repair aortic aneurysm.

Eligibility criteria

Qualifiers

Thoracoabdominal aortic aneurysm with a diameter ≥ 5.5 cm or 2 times the normal aortic diameter.

Aneurysm with a history of growth ≥ 0.5 cm per year.

Saccular aneurysms deemed at significant risk for rupture based upon physician interpretation.

Presence of concomitant thoracoabdominal and aortic arch aneurysm meeting one of the above-mentioned criteria.

Disqualifiers

Less than 18 years of age

Unwilling to comply with the follow-up schedule

Inability or refusal to give informed consent by the patient or a legally authorized representative

Pregnant or breastfeeding

Trial design

Treatments tested in this trial

  • CAAA and TAAA Arm
  • Aortic Arch Aneurysm Arm

Treatment groups

760 Participants
are divided into 2 treatment groups

Locations

3
Mayo Clinic55905, RochesterMinnesota, United States
Baylor College of Medicine77030, HoustonTexas, United States
University of Texas Health Science Center at Houston77089, HoustonTexas, United States

Sponsors and collaborators

Baylor College of Medicine

Lead sponsor

William Cook Australia

Collaborator